Added to YB: 2023-09-29
Pitch date: 2023-09-29
ARWR:US [bullish]
Arrowhead Pharmaceuticals, Inc.
+164.29%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.
Market Cap
$5.7B
Pitch Price
$26.52
Price Target
N/A
Dividend
N/A
EV/EBITDA
-104.33
P/E
-36.25
EV/Sales
9.63
Sector
Biotechnology
Category
N/A
Show full summary:
Arrowhead Pharmaceuticals, Inc. ARWR:US
A summary for this pitch has not been created yet.
Read full article (0 min)